The commercialisation of Provectus’s leading algae manufacturing technology has the potential to expand supply and feed-stock for protein-based drugs treating infectious, inflammatory and cardiovascular diseases. More widely, this valuable and flexible resource can be used in plant-based protein products, for flavourings and could be employed to clean air and wastewater.
See https://www.amgc.org.au/news/amgc-backs-provectus-algaes-blooming-great-idea/